{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:18:09Z","timestamp":1793888289824,"version":"4.8.0"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>RA is characterized by the presence of autoantibodies among which rheumatoid factors (RFs) and antimodified protein antibodies (AMPA) are serological hallmarks of the disease. In recent years, several novel insights into the biology, immunogenetics and clinical relevance of these autoantibodies have been obtained, which deserve to be discussed in more detail.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>RFs from RA patients seem to target distinct epitopes which appear to be quite specific for RA. Determination of immunoglobulin A (IgA) isotypes of RF and anticitrullinated protein antibodies (ACPA) may provide prognostic information because their presence is associated with reduced therapeutic responses to TNF inhibitors. Furthermore, IgA levels are increased in RA patients and IgA immune complexes are more potent than immunoglobulin G (IgG) complexes in inducing NET formation. Concerning AMPAs, investigations on variable domain glycosylation (VDG) revealed effects on antigen binding and activation of autoreactive B cells. Studies on pathogenetic involvement of ACPA suggest Janus-faced roles: on the one hand, ACPA may be involved in joint destruction and pain perception while on the other hand protective anti-inflammatory effects may be attributed to a subset of ACPAs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>The autoimmune response in RA is extremely complex and still far from being fully understood. Antibodies are not only valuable diagnostic biomarkers but also seem to play pivotal roles in the pathophysiology of RA.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000001006","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T12:00:38Z","timestamp":1709035238000},"page":"217-224","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":69,"title":["Autoantibodies in rheumatoid arthritis \u2013 rheumatoid factor, anticitrullinated protein antibodies and beyond"],"prefix":"10.1097","volume":"36","author":[{"given":"G\u00fcnter","family":"Steiner","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine III; Medical University of Vienna"},{"name":"Ludwig Boltzmann Institute for Arthritis and Rehabilitation, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9 E.M.","family":"Toes","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,2,26]]},"reference":[{"key":"R1-20250526","doi-asserted-by":"crossref","first-page":"102392","DOI":"10.1016\/j.jaut.2019.102392","article-title":"An overview of autoantibodies in rheumatoid arthritis","volume":"110","author":"van Delft","year":"2020","journal-title":"J Autoimmun"},{"key":"R2-20250526","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s12016-021-08890-1","article-title":"Autoantibodies in rheumatoid arthritis: historical background and novel findings","volume":"63","author":"Sokolova","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"R3-20250526","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nrrheum.2017.15","article-title":"Beyond citrullination: other posttranslational protein modifications in rheumatoid arthritis","volume":"13","author":"Trouw","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"R5-20250526","doi-asserted-by":"crossref","first-page":"e003480","DOI":"10.1136\/rmdopen-2023-003480","article-title":"Antibodies against advanced glycation end-products and malondialdehyde-acetaldehyde adducts identify a new specific subgroup of hitherto patients with seronegative arthritis with a distinct clinical phenotype and an HLA class II association","volume":"9","author":"van den Beukel","year":"2023","journal-title":"RMD Open"},{"key":"R6-20250526","first-page":"554","article-title":"Seronegative rheumatoid arthritis: one year in review","volume":"41","author":"De Stefano","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"R7-20250526","first-page":"103421","article-title":"Should ACR\/EULAR criteria be revised changing the RF and ACPA scores?","author":"Steiner","year":"2023","journal-title":"Autoimmun Rev"},{"key":"R8-20250526","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/annrheumdis-2017-212627","article-title":"Number of individual ACPA reactivities in synovial fluid immune complexes, but not serum anti-CCP2 levels, associate with inflammation and joint destruction in rheumatoid arthritis","volume":"77","author":"Sohrabian","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R9-20250526","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13075-020-02169-0","article-title":"Cartilage-binding antibodies initiate joint inflammation and promote chronic erosive arthritis","volume":"22","author":"Li","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"R10-20250526","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13075-022-02945-0","article-title":"Rheumatoid arthritis sera antibodies to citrullinated collagen type II bind to joint cartilage","volume":"24","author":"Li","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"R11-20250526","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/art.40562","article-title":"Triple positivity for anti-citrullinated protein autoantibodies, rheumatoid factor, and anti-carbamylated protein antibodies conferring high specificity for rheumatoid arthritis: implications for very early identification of at-risk individuals","volume":"70","author":"Verheul","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"R12-20250526","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13075-016-0940-2","article-title":"Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis","volume":"18","author":"Brink","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"R13-20250526","doi-asserted-by":"crossref","first-page":"e002817","DOI":"10.1136\/rmdopen-2022-002817","article-title":"Rheumatoid factor isotypes in rheumatoid arthritis diagnosis and prognosis: a systematic review and meta-analysis","volume":"9","author":"Motta","year":"2023","journal-title":"RMD Open"},{"key":"R14-20250526","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1515\/cclm-2022-0244","article-title":"IgA rheumatoid factor in rheumatoid arthritis","volume":"60","author":"Van Hoovels","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"R15-20250526","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/ard.2006.060608","article-title":"High IgA rheumatoid factor levels are associated with poor clinical response to tumour necrosis factor alpha inhibitors in rheumatoid arthritis","volume":"66","author":"Bobbio-Pallavicini","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R16-20250526","doi-asserted-by":"crossref","first-page":"1096866","DOI":"10.3389\/fimmu.2022.1096866","article-title":"The diagnostic and prognostic value of IgG and IgA anticitrullinated protein antibodies in patients with early rheumatoid arthritis","volume":"13","author":"Sieghart","year":"2022","journal-title":"Front Immunol"},{"key":"R17-20250526","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1136\/ard-2023-223901","article-title":"Rheumatoid factor autoantibody repertoire profiling reveals distinct binding epitopes in health and autoimmunity","volume":"82","author":"Oskam","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"R18-20250526","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41467-019-13992-8","article-title":"IgA subclasses have different effector functions associated with distinct glycosylation profiles","volume":"11","author":"Steffen","year":"2020","journal-title":"Nat Commun"},{"key":"R19-20250526","doi-asserted-by":"crossref","first-page":"761816","DOI":"10.3389\/fimmu.2021.761816","article-title":"IgA complexes induce neutrophil extracellular trap formation more potently than IgG complexes","volume":"12","author":"Gimpel","year":"2021","journal-title":"Front Immunol"},{"key":"R20-20250526","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/rheumatology\/keac237","article-title":"In rheumatoid arthritis patients, total IgA1 and IgA2 levels are elevated: implications for the mucosal origin hypothesis","volume":"62","author":"Derksen","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"R21-20250526","article-title":"In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation","author":"Pertsinidou","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"R22-20250526","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/annrheumdis-2019-216499","article-title":"Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other posttranslational modifications","volume":"79","author":"Kissel","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"R23-20250526","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/art.41385","article-title":"Different hierarchies of anti-modified protein autoantibody reactivities in rheumatoid arthritis","volume":"72","author":"Sahlstrom","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"R24-20250526","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/art.40698","article-title":"Structural basis of cross-reactivity of anti-citrullinated protein antibodies","volume":"71","author":"Ge","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R25-20250526","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41584-019-0244-4","article-title":"The structure, specificity and function of anticitrullinated protein antibodies","volume":"15","author":"Ge","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"R26-20250526","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.1114465108","article-title":"Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage","volume":"108","author":"Shi","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"R27-20250526","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/annrheumdis-2014-206785","article-title":"Identification of novel antiacetylated vimentin antibodies in patients with early inflammatory arthritis","volume":"75","author":"Juarez","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R28-20250526","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X211022533","article-title":"Presence of antiacetylated peptide antibodies (AAPA) in inflammatory arthritis and other rheumatic diseases suggests discriminative diagnostic capacity towards early rheumatoid arthritis","volume":"13","author":"Studenic","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"R29-20250526","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/annrheumdis-2014-206598","article-title":"Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis","volume":"75","author":"Rombouts","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R30-20250526","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/annrheumdis-2017-212052","article-title":"B-cell receptor sequencing of anticitrullinated protein antibody (ACPA) IgG-expressing B cells indicates a selective advantage for the introduction of N-glycosylation sites during somatic hypermutation","volume":"77","author":"Vergroesen","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R31-20250526","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1074\/mcp.M116.062919","article-title":"Structural analysis of variable domain glycosylation of anti-citrullinated protein antibodies in rheumatoid arthritis reveals the presence of highly sialylated glycans","volume":"16","author":"Hafkenscheid","year":"2017","journal-title":"Mol Cell Proteomics"},{"key":"R32-20250526","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/art.40920","article-title":"N-Linked glycans in the variable domain of IgG anti-citrullinated protein antibodies predict the development of rheumatoid arthritis","volume":"71","author":"Hafkenscheid","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R33-20250526","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/annrheumdis-2021-220841","article-title":"Genetic predisposition (HLA-SE) is associated with ACPA-IgG variable domain glycosylation in the predisease phase of RA","volume":"81","author":"Kissel","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"R34-20250526","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.jaci.2022.10.035","article-title":"Differences in IgG autoantibody Fab glycosylation across autoimmune diseases","volume":"151","author":"Koers","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"R35-20250526","doi-asserted-by":"crossref","first-page":"eabm1759","DOI":"10.1126\/sciadv.abm1759","article-title":"Surface Ig variable domain glycosylation affects autoantigen binding and acts as threshold for human autoreactive B cell activation","volume":"8","author":"Kissel","year":"2022","journal-title":"Sci Adv"},{"key":"R36-20250526","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/annrheumdis-2015-208094","article-title":"Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism","volume":"75","author":"Wigerblad","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R37-20250526","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/annrheumdis-2015-208093","article-title":"Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss","volume":"75","author":"Krishnamurthy","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R38-20250526","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1084\/jem.2012148612112018r","article-title":"Retraction: Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition","volume":"216","author":"Amara","year":"2019","journal-title":"J Exp Med"},{"key":"R39-20250526","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/annrheumdis-2019-215337","article-title":"Pathogenic effector functions of ACPA: where do we stand?","volume":"78","author":"Toes","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R40-20250526","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/art.42320","article-title":"Combination of two monoclonal anti-citrullinated protein antibodies induced tenosynovitis, pain, and bone loss in mice in a peptidyl arginine deiminase-4-dependent manner","volume":"75","author":"Krishnamurthy","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"R41-20250526","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbi.2023.07.001","article-title":"Insights into FcgammaR involvement in pain-like behavior induced by an RA-derived antimodified protein autoantibody","volume":"113","author":"Jurczak","year":"2023","journal-title":"Brain Behav Immun"},{"key":"R42-20250526","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/j.pain.0000000000002543","article-title":"Antibody-induced pain-like behavior and bone erosion: links to subclinical inflammation, osteoclast activity, and acid-sensing ion channel 3-dependent sensitization","volume":"163","author":"Jurczak","year":"2022","journal-title":"Pain"},{"key":"R43-20250526","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/s41423-020-0381-3","article-title":"Therapeutic ACPA inhibits NET formation: a potential therapy for neutrophil-mediated inflammatory diseases","volume":"18","author":"Chirivi","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"R44-20250526","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41467-023-36257-x","article-title":"A subset of antibodies targeting citrullinated proteins confers protection from rheumatoid arthritis","volume":"14","author":"He","year":"2023","journal-title":"Nat Commun"},{"key":"R45-20250526","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/ard-2022-223417","article-title":"Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development","volume":"82","author":"Raposo","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"R46-20250526","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/art.42679","article-title":"Anti-citrullinated protein antibodies with multiple specificities ameliorate collagen antibody-induced arthritis in a time-dependent manner","volume":"76","author":"Gomez","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"R47-20250526","doi-asserted-by":"crossref","first-page":"2281763","DOI":"10.1080\/19420862.2023.2281763","article-title":"Anticitrullinated histone monoclonal antibody CIT-013, a dual action therapeutic for neutrophil extracellular trap-associated autoimmune diseases","volume":"15","author":"van der Linden","year":"2023","journal-title":"MAbs"},{"key":"R48-20250526","doi-asserted-by":"crossref","first-page":"eaaz5327","DOI":"10.1126\/scitranslmed.aaz5327","article-title":"Persistently activated, proliferative memory autoreactive B cells promote inflammation in rheumatoid arthritis","volume":"12","author":"Kristyanto","year":"2020","journal-title":"Sci Transl Med"},{"key":"R49-20250526","doi-asserted-by":"crossref","first-page":"e172006","DOI":"10.1172\/jci.insight.172006","article-title":"Autoreactive B cells in rheumatoid arthritis include mainly activated CXCR3+ memory B cells and plasmablasts","volume":"8","author":"Reijm","year":"2023","journal-title":"JCI Insight"},{"key":"R50-20250526","doi-asserted-by":"crossref","first-page":"eabq8476","DOI":"10.1126\/scitranslmed.abq8476","article-title":"Oral mucosal breaks trigger anticitrullinated bacterial and human protein antibody responses in rheumatoid arthritis","volume":"15","author":"Brewer","year":"2023","journal-title":"Sci Transl Med"},{"key":"R51-20250526","doi-asserted-by":"crossref","first-page":"e2204607119","DOI":"10.1073\/pnas.2204607119","article-title":"Early human B cell signatures of the primary antibody response to mRNA vaccination","volume":"119","author":"Kardava","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"R52-20250526","doi-asserted-by":"crossref","first-page":"100142","DOI":"10.1016\/j.jtauto.2022.100142","volume":"5","author":"Van Hoovels","year":"2022","journal-title":"J Transl Autoimmun"},{"key":"R53-20250526","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1136\/annrheumdis-2021-221849","article-title":"Standardisation of ACPA tests: evaluation of a new candidate reference preparation","volume":"81","author":"Van Hoovels","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"R54-20250526","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-002099","article-title":"Multicentre study to improve clinical interpretation of rheumatoid factor and anticitrullinated protein\/peptide antibodies test results","volume":"8","author":"Van Hoovels","year":"2022","journal-title":"RMD Open"},{"key":"R55-20250526","doi-asserted-by":"crossref","first-page":"988","DOI":"10.55563\/clinexprheumatol\/vlvlqu","article-title":"Antibody to peptidoglycan recognition protein (PGLYRP)-2 as a novel biomarker in rheumatoid arthritis","volume":"39","author":"Huang","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"R56-20250526","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/annrheumdis-2020-218460","article-title":"Novel autoantibodies identified in ACPA-negative rheumatoid arthritis","volume":"80","author":"Li","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"R57-20250526","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.3390\/molecules27041452","article-title":"Functional analysis of autoantibody signatures in rheumatoid arthritis","volume":"27","author":"Milchram","year":"2022","journal-title":"Molecules"},{"key":"R58-20250526","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/art.42463","article-title":"Autoantibodies to disease-related proteins in joints as novel biomarkers for the diagnosis of rheumatoid arthritis","volume":"75","author":"Lonnblom","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"R59-20250526","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13075-020-02191-2","article-title":"Presence of autoantibodies in \u201cseronegative\u201d rheumatoid arthritis associates with classical risk factors and high disease activity","volume":"22","author":"Reed","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"R60-20250526","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/annrheumdis-2017-211782","article-title":"Anticitrullinated protein\/peptide antibody multiplexing defines an extended group of ACPA-positive rheumatoid arthritis patients with distinct genetic and environmental determinants","volume":"77","author":"Ronnelid","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R61-20250526","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3389\/fimmu.2018.00876","article-title":"Determination of autoantibody isotypes increases the sensitivity of serodiagnostics in rheumatoid arthritis","volume":"9","author":"Sieghart","year":"2018","journal-title":"Front Immunol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T21:17:51Z","timestamp":1748294271000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,26]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000001006","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,26]]}}}